Bortezomib in mantle cell lymphoma

By Suh K Stephen   Goy Andre  

Future Oncology, Vol. 4, Iss. 2, 2008-04 ,pp. : 149-168

Future Medicine

Access to resources Recommend Favorite

Mantle cell lymphoma presenting with paraproteinemia

By Rymkiewicz Grzegorz   Gos Monika   Błachnio Katarzyna   Woroniecka Renata   Swoboda Paweł   Pieńkowska-Grela Barbara   Kulińska Marika   Borawska Anna   Janik Przemysław   Walewski Jan  

Medical Oncology, Vol. 22, Iss. 3, 2005-09 ,pp. : 319-323

Humana Press, Inc

Access to resources Recommend Favorite

A Danish population-based analysis of 105 mantle cell lymphoma patients - incidences, clinical features, response, survival and prognostic factors

By Andersen N.S.   Jensen M.K.   de Nully Brown P.   Geisler C.H.  

European Journal of Cancer, Vol. 38, Iss. 3, 2002-01 ,pp. : 401-408

Elsevier

Access to resources Recommend Favorite

Molecular outcome prediction in mantle cell lymphoma

By Hartmann Elena M   Ott German   Rosenwald Andreas  

Future Oncology, Vol. 5, Iss. 1, 2009-02 ,pp. : 63-73

Future Medicine

Access to resources Recommend Favorite

ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma

By Dreyling M.   Thieblemont C.   Gallamini A.   Arcaini L.   Campo E.   Hermine O.   Kluin-Nelemans J. C.   Ladetto M.   Le Gouill S.   Iannitto E.   Pileri S.   Rodriguez J.   Schmitz N.   Wotherspoon A.   Zinzani P.   Zucca E.  

Annals of Oncology, Vol. 24, Iss. 4, 2013-04 ,pp. : 857-877

Oxford University Press

Access to resources Recommend Favorite